Company intelligence / Profile preview

SDS Life Science

Danderyd, Stockholm, Sweden

Ownership: Private
Employees: ~50
Development stage: Other

Overview

SDS Life Science is a leading Scandinavian consulting firm that provides comprehensive drug development and regulatory services. It specializes in biostatistics, regulatory affairs, and project management for pharmaceutical, biotech, and medtech companies. In 2022, the company was acquired by Cytel to strengthen its footprint in the Nordic region and enhance its global strategic consulting capabilities.

Industry: Consulting

Partnerships

SwedenBIOOslo Cancer ClusterNorway Health Tech

Beyond the preview

Go deeper on SDS Life Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SDS Life Science.

Explore the full profile